Does ELIQUIS Cause International normalised ratio increased? 15 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of International normalised ratio increased have been filed in association with ELIQUIS. This represents 1.1% of all adverse event reports for ELIQUIS.
15
Reports of International normalised ratio increased with ELIQUIS
1.1%
of all ELIQUIS reports
2
Deaths
5
Hospitalizations
How Dangerous Is International normalised ratio increased From ELIQUIS?
Of the 15 reports, 2 (13.3%) resulted in death, 5 (33.3%) required hospitalization.
Is International normalised ratio increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELIQUIS. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does ELIQUIS Cause?
Haemorrhage (79)
Gastrointestinal haemorrhage (72)
Dizziness (65)
Rash (51)
Epistaxis (49)
Headache (49)
Dyspnoea (41)
Adverse event (40)
Diarrhoea (37)
Contusion (34)
What Other Drugs Cause International normalised ratio increased?
WARFARIN (5,622)
RIVAROXABAN (863)
ACETAMINOPHEN (533)
ASPIRIN (448)
APIXABAN (317)
CLOPIDOGREL BISULFATE (314)
FLUINDIONE (286)
AMIODARONE (277)
FUROSEMIDE (277)
DABIGATRAN ETEXILATE (223)
Which ELIQUIS Alternatives Have Lower International normalised ratio increased Risk?
ELIQUIS vs ELOSULFASE ALFA
ELIQUIS vs ELOTUZUMAB
ELIQUIS vs ELOXATIN
ELIQUIS vs ELRANATAMAB
ELIQUIS vs ELRANATAMAB-BCMM